BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26408084)

  • 1. Reply.
    Jernigan A
    Am J Obstet Gynecol; 2016 Jan; 214(1):139. PubMed ID: 26408084
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of bariatric surgery in obese women with endometrial cancer risk.
    Sanguankeo A; Upala S
    Am J Obstet Gynecol; 2016 Jan; 214(1):138-9. PubMed ID: 26408083
    [No Abstract]   [Full Text] [Related]  

  • 3. Referring survivors of endometrial cancer and complex atypical hyperplasia to bariatric specialists: a prospective cohort study.
    Jernigan AM; Maurer KA; Cooper K; Schauer PR; Rose PG; Michener CM
    Am J Obstet Gynecol; 2015 Sep; 213(3):350.e1-10. PubMed ID: 25981846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Masciullo V; Trivellizzi N; Zannoni G; Catena U; Moroni R; Fanfani F; Scambia G
    Am J Obstet Gynecol; 2021 Apr; 224(4):408-410. PubMed ID: 33385345
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
    Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
    Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Corrado G; Baiocco E; Carosi M; Vizza E
    Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments on "SEOM guidelines for endometrial cancer".
    Vergés R
    Clin Transl Oncol; 2012 Dec; 14(12):961-2. PubMed ID: 23150217
    [No Abstract]   [Full Text] [Related]  

  • 8. Take 'em or leave 'em: management of the ovaries in young women with endometrial cancer.
    Wright JD
    Gynecol Oncol; 2013 Nov; 131(2):287-8. PubMed ID: 24139060
    [No Abstract]   [Full Text] [Related]  

  • 9. Endometrial carcinoma and its precursors.
    Berchuck A
    Curr Ther Endocrinol Metab; 1997; 6():599-602. PubMed ID: 9174814
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the editor in response to "Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence".
    Pollock J
    Gynecol Oncol; 2010 Jun; 117(3):507; author reply 507-8. PubMed ID: 20189231
    [No Abstract]   [Full Text] [Related]  

  • 11. Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome.
    Wright JD; Lewin SN; Barrena Medel NI; Sun X; Burke WM; Deutsch I; Herzog TJ
    Gynecol Oncol; 2011 Jul; 122(1):69-74. PubMed ID: 21429570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of bilateral primary endometroid adenocarcinoma of the fallopian tubes.
    Abuzoda U; Preston J
    J Obstet Gynaecol; 2002 Sep; 22(5):571-2. PubMed ID: 12521447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endometrial hyperplasia predicts a better prognosis in endometrial carcinoma].
    Mihailovici MS; Teleman S
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):367-70. PubMed ID: 14755942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservative treatment of endometrial cancer and atypical hyperplasia].
    Yazbeck C; Dhainaut C; Thoury A; Driguez P; Madelenat P
    Gynecol Obstet Fertil; 2004 May; 32(5):433-41. PubMed ID: 15177216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How often does cervical involvement upstage patients with non-myoinvasive (otherwise stage 1A) endometrioid adenocarcinoma of the endometrium?
    Fadare O; Desrosiers L; Xiao ZF; Wang SA
    Virchows Arch; 2007 May; 450(5):601-2. PubMed ID: 17406893
    [No Abstract]   [Full Text] [Related]  

  • 16. Endometrial endometrioid carcinoma: a glimpse at the natural course.
    Levy T; Golan A; Menczer J
    Am J Obstet Gynecol; 2006 Aug; 195(2):454-7. PubMed ID: 16626613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
    Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
    Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous primary ovarian and endometrial cancer with a fair prognosis in a young woman.
    Yang YH; Chen RJ; Lin MC; Cheng SP; Chang TC
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):97-100. PubMed ID: 20466303
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of endometrioid adenocarcinoma despite Levonorgestrel-releasing intrauterine system: a case report with discussion and review of the RCOG/BSGE Guideline on the Management of Endometrial Hyperplasia.
    van der Meer AC; Hanna LS
    Clin Obes; 2017 Feb; 7(1):54-57. PubMed ID: 27984850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
    Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JE; Holst J
    Int J Cancer; 2016 Dec; 139(11):2529-39. PubMed ID: 27486861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.